mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-09 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.25 |
1e-05 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.24 |
2e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
4e-05 |